Leukemia Clinical Trials in Nashville

Showing 781-800 of 1,768 trials

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

NCT05271292

This is a Phase 1b/2, single-arm, open-label, dose-escalation study including 2 stages: Phase 1b: Dose-Escalation Stage (Single-Dose and Consecutive-Dose Periods) Phase 2: recommended Phase 2 dose (RP2D) of chiauranib will be given to all patients enrolled in this phase once daily for 28-day cycles continuously with no interruption between cycles.

Small Cell Lung CancerAdvanced Solid Malignant Tumor

Chipscreen Biosciences, Ltd.36 participantsStarted Aug 2022

Encinitas, California, United States • Fullerton, California, United States • Atlanta, Georgia, United States +8 more locations

TERMINATEDPhase 1< 1 mile

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

NCT05769959

The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, immune response and preliminary anti-tumor activity of RO7515629 alone in participants with advanced or metastatic solid tumors expressing human leukocyte antigen G (HLA-G).

Renal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more

Hoffmann-La Roche3 participantsStarted Jun 2023

Denver, Colorado, United States • Nashville, Tennessee, United States

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Leukemia Trials in Other Cities

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

House Dust Mite Allergy Trial In Children

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Efficacy of Ginseng for Patients on Regorafenib

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

Other Conditions in Nashville